Ftse Mib
35.090,23
-0,64%
DAX
20.214,79
-0,51%
S&P 500
5.827,04
-1,54%
NASDAQ
19.161,63
-1,63%
Bitcoin
94.750,21
0,19%
Pepperstone
Advertisement
Registration Strip Icon for default Registrati gratuitamente per ottenere quotazioni in tempo reale, grafici interattivi, flusso di opzioni in tempo reale e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ 23andMe Holding Company (ME) 23andMe Holding Company (ME) Notizie

23andMe Holding Company

ME
3,84
-0,21 (-5,19%)
11 Gen 2025 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
08/1/202513:30GLOBE23andMe Launches Discover23 to Help Accelerate Large-Scale..
21/11/202422:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/11/202413:30GLOBE23andMe and Mirador Therapeutics Enter Into Strategic..
16/11/202403:17EDGAR2Form 144 - Report of proposed sale of securities
16/11/202403:10EDGAR2Form 144 - Report of proposed sale of securities
15/11/202422:48EDGAR2Form SC 13D/A - General Statement of Acquisition of..
13/11/202412:00EDGAR2Form SC 13G - Statement of Beneficial Ownership by Certain..
12/11/202413:30GLOBE23andMe Reports Second Quarter Fiscal Year 2025 Financial..
11/11/202423:30GLOBE23andMe Announces Business Restructuring to Streamline..
07/11/202423:54GLOBECORRECTION - 23andMe to Report Q2 FY2025 Financial Results
07/11/202413:30GLOBE23andMe to Report Q2 FY2025 Financial Results
30/10/202422:05EDGAR2Form 8-K - Current report
30/10/202422:00GLOBE23andMe Regains Compliance With Nasdaq Listing Requirements
29/10/202421:27EDGAR2Form SC 13D/A - General Statement of Acquisition of..
29/10/202421:06EDGAR2Form 8-K - Current report
29/10/202412:30GLOBE23andMe Appoints Three New Independent Directors to Board
17/10/202422:05GLOBE23andMe Introduces New Feature Helping African Americans..
16/10/202414:21EDGAR2Form 8-K - Current report
16/10/202414:15GLOBE23andMe Announces Completion of 1-for-20 Reverse Stock Split
11/10/202414:15GLOBE23andMe Announces 1-for-20 Reverse Stock Split
08/10/202413:00GLOBE23andMe Announces Mathew Knowles as New Brand Ambassador
30/9/202422:58EDGAR2Form SC 13D/A - General Statement of Acquisition of..
25/9/202413:30GLOBE23andMe Launches New Genetic Report on Likelihood of..
18/9/202422:39EDGAR2Form 8-K - Current report
18/9/202414:10EDGAR2Form SC 13D/A - General Statement of Acquisition of..
18/9/202414:05EDGAR2Form 8-K - Current report
18/9/202412:13IHMARKETNEWSMeta Strengthens Child Privacy on Instagram; Google..
17/9/202422:26GLOBEIndependent Directors of 23andMe Resign from Board
15/9/202409:00GLOBE23andMe Therapeutics Announces Phase 2 Results for Two..
12/9/202422:05GLOBEOne of the Largest and Most Diverse Studies on Sickle Cell..
12/9/202412:02IHMARKETNEWSNorfolk Southern CEO Fired, Ryanair Lowers Fare Forecast,..
11/9/202422:45EDGAR2Form SC 13D/A - General Statement of Acquisition of..
03/9/202413:30GLOBE23andMe to Present Updates on Clinical Immuno-oncology..
28/8/202422:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/8/202422:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/8/202413:30GLOBELemonaid Health Now Offering GLP-1 Medication Through Weight..
27/8/202422:08EDGAR2Form 8-K - Current report
21/8/202423:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/8/202423:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/8/202422:11EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/8/202422:06EDGAR2Form 8-K - Current report
08/8/202422:05GLOBE23andMe Reports First Quarter Fiscal 2025 Financial Results
05/8/202411:43IHMARKETNEWSNvidia AI Chip Delays, Mars Eyes Kellanova Acquisition,..
02/8/202414:19EDGAR2Form 8-K - Current report
02/8/202414:00GLOBE23andMe Special Committee responds to CEO’s take-private..
01/8/202414:09EDGAR2Form 8-K - Current report
01/8/202414:00GLOBE23andMe Announces CEO’s Take-Private Proposal
31/7/202423:01EDGAR2Form SC 13D/A - General Statement of Acquisition of..
25/7/202422:45GLOBE23andMe to Report Q1 FY2025 Financial Results
25/7/202413:30GLOBETwenty Lung Cancer Advocacy Organizations and 23andMe Come..
Apertura: 4,00 Min: 3,825 Max: 4,06
Chiusura: 4,05

La tua Cronologia

NASDAQ
ME
23andMe
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network